Global Formulation Development CDMO Market Growth (Status and Outlook) 2026-2032
The global Formulation Development CDMO market size is predicted to grow from US$ 18890 million in 2025 to US$ 29040 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.
Formulation Development CDMO refers to a contract research and manufacturing organization that provides pharmaceutical companies with end-to-end outsourcing services for drug formulation, from formulation design to finished product manufacturing. Its core mission is to combine active pharmaceutical ingredients (APIs) and excipients to develop stable, safe, effective, and scalable final dosage forms, such as tablets, capsules, injections, and inhalers. Services encompass pre-formulation studies (determination of API physicochemical properties and excipient compatibility), formulation screening and optimization, process development (such as wet granulation, hot melt extrusion, and aseptic filling), analytical method development, stability studies, and GMP-compliant clinical sample and commercial batch production. Its value lies in helping clients accelerate formulation development, reduce upfront infrastructure and personnel investment, and overcome technical bottlenecks associated with poorly soluble drugs, complex injections, or special dosage forms. It is a crucial translational step from drug candidate compounds to clinical trials and the market.
The global Formulation Development CDMO market is dominated by Europe and the US, with Asia catching up. North America leads with its mature biopharmaceutical ecosystem and complex formulation (liposomes, nanoparticles) technology, with Thermo Fisher and Catalent dominating the high-end market; however, overcapacity and price competition are emerging. Europe, relying on companies like Lonza with its strong foundation in oral solid dosage forms and sterile injectables, benefits from strong demand from small and medium-sized biotechnology companies; however, energy costs and fragmented regulations constrain expansion. China, represented by WuXi AppTec and Asymchem, is gaining market share in conventional oral and injectable dosage forms thanks to cost advantages and rapid delivery capabilities, and is accelerating its penetration into complex formulations; however, the quality of excipients and reliance on imported high-end equipment remain weaknesses. Japan has solid technology in transdermal patches and microsphere formulations, but its CDMO scale is relatively limited due to slow growth in its domestic market and a low proportion of outsourced new drug development. Future trends include: continuous manufacturing replacing batch production processes, AI-assisted formulation design shortening development cycles, and explosive demand for novel formulations such as gene therapy vectors and mRNA vaccines. The main obstacles include: high failure rates in the development of complex formulations, monopolies in the supply of key excipients, and increased compliance costs due to regulatory differences among countries under global multi-center filings. Dynamically, leading companies are building differentiated barriers through mergers and acquisitions and technology licensing (such as liposome platform licensing), while extending their service chains to both early-stage R&D and commercialization.
LPI (LP Information)' newest research report, the ?Formulation Development CDMO Industry Forecast? looks at past sales and reviews total world Formulation Development CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Formulation Development CDMO sales for 2026 through 2032. With Formulation Development CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Formulation Development CDMO industry.
This Insight Report provides a comprehensive analysis of the global Formulation Development CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Formulation Development CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Formulation Development CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Formulation Development CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Formulation Development CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Formulation Development CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Formulation Development CDMO refers to a contract research and manufacturing organization that provides pharmaceutical companies with end-to-end outsourcing services for drug formulation, from formulation design to finished product manufacturing. Its core mission is to combine active pharmaceutical ingredients (APIs) and excipients to develop stable, safe, effective, and scalable final dosage forms, such as tablets, capsules, injections, and inhalers. Services encompass pre-formulation studies (determination of API physicochemical properties and excipient compatibility), formulation screening and optimization, process development (such as wet granulation, hot melt extrusion, and aseptic filling), analytical method development, stability studies, and GMP-compliant clinical sample and commercial batch production. Its value lies in helping clients accelerate formulation development, reduce upfront infrastructure and personnel investment, and overcome technical bottlenecks associated with poorly soluble drugs, complex injections, or special dosage forms. It is a crucial translational step from drug candidate compounds to clinical trials and the market.
The global Formulation Development CDMO market is dominated by Europe and the US, with Asia catching up. North America leads with its mature biopharmaceutical ecosystem and complex formulation (liposomes, nanoparticles) technology, with Thermo Fisher and Catalent dominating the high-end market; however, overcapacity and price competition are emerging. Europe, relying on companies like Lonza with its strong foundation in oral solid dosage forms and sterile injectables, benefits from strong demand from small and medium-sized biotechnology companies; however, energy costs and fragmented regulations constrain expansion. China, represented by WuXi AppTec and Asymchem, is gaining market share in conventional oral and injectable dosage forms thanks to cost advantages and rapid delivery capabilities, and is accelerating its penetration into complex formulations; however, the quality of excipients and reliance on imported high-end equipment remain weaknesses. Japan has solid technology in transdermal patches and microsphere formulations, but its CDMO scale is relatively limited due to slow growth in its domestic market and a low proportion of outsourced new drug development. Future trends include: continuous manufacturing replacing batch production processes, AI-assisted formulation design shortening development cycles, and explosive demand for novel formulations such as gene therapy vectors and mRNA vaccines. The main obstacles include: high failure rates in the development of complex formulations, monopolies in the supply of key excipients, and increased compliance costs due to regulatory differences among countries under global multi-center filings. Dynamically, leading companies are building differentiated barriers through mergers and acquisitions and technology licensing (such as liposome platform licensing), while extending their service chains to both early-stage R&D and commercialization.
LPI (LP Information)' newest research report, the ?Formulation Development CDMO Industry Forecast? looks at past sales and reviews total world Formulation Development CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Formulation Development CDMO sales for 2026 through 2032. With Formulation Development CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Formulation Development CDMO industry.
This Insight Report provides a comprehensive analysis of the global Formulation Development CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Formulation Development CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Formulation Development CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Formulation Development CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Formulation Development CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Formulation Development CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Oral Solid Dosage Forms
- Injectable Dosage Forms
- Transdermal Dosage Forms
- Others
- 3 Months
- 6 Months
- 12 Months
- 24 Months
- Others
- Small molecule chemical drugs
- Biologics
- Cell and gene therapy products
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Ascendia Pharmaceutical Solutions
- Catalent
- Cambrex
- Ser?n Bioscience
- Singota Solutions
- Adragos Pharma
- Meribel Pharma
- Eurofins CDMO
- Skyepharma
- Siegfried Group
- Recipharm
- CordenPharma
- Thermo Fisher Scientific
- Samsung Biologics
- AGC Biologics
- WuXi AppTec
- Pharmaron
- Asymchem
- Huahai Pharma
- Nipro Pharma
- CMIC Group
- Hovione
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Formulation Development CDMO Market Size (2021-2032)
2.1.2 Formulation Development CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Formulation Development CDMO by Country/Region (2021, 2025 & 2032)
2.2 Formulation Development CDMO Segment by Type
2.2.1 Oral Solid Dosage Forms
2.2.2 Injectable Dosage Forms
2.2.3 Transdermal Dosage Forms
2.2.4 Others
2.2.5 Formulation Development CDMO Market Size by Type
2.2.5.1 Formulation Development CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Formulation Development CDMO Market Size Market Share by Type (2021-2026)
2.3 Formulation Development CDMO Segment by Service Period
2.3.1 3 Months
2.3.2 6 Months
2.3.3 12 Months
2.3.4 24 Months
2.3.5 Others
2.3.6 Formulation Development CDMO Market Size by Service Period
2.3.6.1 Formulation Development CDMO Market Size CAGR by Service Period (2021 VS 2025 VS 2032)
2.3.6.2 Global Formulation Development CDMO Market Size Market Share by Service Period (2021-2026)
2.4 Formulation Development CDMO Segment by Application
2.4.1 Small molecule chemical drugs
2.4.2 Biologics
2.4.3 Cell and gene therapy products
2.4.4 Others
2.4.5 Formulation Development CDMO Market Size by Application
2.4.5.1 Formulation Development CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.5.2 Global Formulation Development CDMO Market Size Market Share by Application (2021-2026)
3 FORMULATION DEVELOPMENT CDMO MARKET SIZE BY PLAYER
3.1 Formulation Development CDMO Market Size Market Share by Player
3.1.1 Global Formulation Development CDMO Revenue by Player (2021-2026)
3.1.2 Global Formulation Development CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Formulation Development CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 FORMULATION DEVELOPMENT CDMO BY REGION
4.1 Formulation Development CDMO Market Size by Region (2021-2026)
4.2 Global Formulation Development CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Formulation Development CDMO Market Size Growth (2021-2026)
4.4 APAC Formulation Development CDMO Market Size Growth (2021-2026)
4.5 Europe Formulation Development CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Formulation Development CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Formulation Development CDMO Market Size by Country (2021-2026)
5.2 Americas Formulation Development CDMO Market Size by Type (2021-2026)
5.3 Americas Formulation Development CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Formulation Development CDMO Market Size by Region (2021-2026)
6.2 APAC Formulation Development CDMO Market Size by Type (2021-2026)
6.3 APAC Formulation Development CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Formulation Development CDMO Market Size by Country (2021-2026)
7.2 Europe Formulation Development CDMO Market Size by Type (2021-2026)
7.3 Europe Formulation Development CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Formulation Development CDMO by Region (2021-2026)
8.2 Middle East & Africa Formulation Development CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Formulation Development CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL FORMULATION DEVELOPMENT CDMO MARKET FORECAST
10.1 Global Formulation Development CDMO Forecast by Region (2027-2032)
10.1.1 Global Formulation Development CDMO Forecast by Region (2027-2032)
10.1.2 Americas Formulation Development CDMO Forecast
10.1.3 APAC Formulation Development CDMO Forecast
10.1.4 Europe Formulation Development CDMO Forecast
10.1.5 Middle East & Africa Formulation Development CDMO Forecast
10.2 Americas Formulation Development CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Formulation Development CDMO Forecast
10.2.2 Canada Market Formulation Development CDMO Forecast
10.2.3 Mexico Market Formulation Development CDMO Forecast
10.2.4 Brazil Market Formulation Development CDMO Forecast
10.3 APAC Formulation Development CDMO Forecast by Region (2027-2032)
10.3.1 China Formulation Development CDMO Market Forecast
10.3.2 Japan Market Formulation Development CDMO Forecast
10.3.3 Korea Market Formulation Development CDMO Forecast
10.3.4 Southeast Asia Market Formulation Development CDMO Forecast
10.3.5 India Market Formulation Development CDMO Forecast
10.3.6 Australia Market Formulation Development CDMO Forecast
10.4 Europe Formulation Development CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Formulation Development CDMO Forecast
10.4.2 France Market Formulation Development CDMO Forecast
10.4.3 UK Market Formulation Development CDMO Forecast
10.4.4 Italy Market Formulation Development CDMO Forecast
10.4.5 Russia Market Formulation Development CDMO Forecast
10.5 Middle East & Africa Formulation Development CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Formulation Development CDMO Forecast
10.5.2 South Africa Market Formulation Development CDMO Forecast
10.5.3 Israel Market Formulation Development CDMO Forecast
10.5.4 Turkey Market Formulation Development CDMO Forecast
10.6 Global Formulation Development CDMO Forecast by Type (2027-2032)
10.7 Global Formulation Development CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Formulation Development CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Formulation Development CDMO Product Offered
11.1.3 Lonza Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Ascendia Pharmaceutical Solutions
11.2.1 Ascendia Pharmaceutical Solutions Company Information
11.2.2 Ascendia Pharmaceutical Solutions Formulation Development CDMO Product Offered
11.2.3 Ascendia Pharmaceutical Solutions Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Ascendia Pharmaceutical Solutions Main Business Overview
11.2.5 Ascendia Pharmaceutical Solutions Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Formulation Development CDMO Product Offered
11.3.3 Catalent Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Cambrex
11.4.1 Cambrex Company Information
11.4.2 Cambrex Formulation Development CDMO Product Offered
11.4.3 Cambrex Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cambrex Main Business Overview
11.4.5 Cambrex Latest Developments
11.5 Ser?n Bioscience
11.5.1 Ser?n Bioscience Company Information
11.5.2 Ser?n Bioscience Formulation Development CDMO Product Offered
11.5.3 Ser?n Bioscience Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Ser?n Bioscience Main Business Overview
11.5.5 Ser?n Bioscience Latest Developments
11.6 Singota Solutions
11.6.1 Singota Solutions Company Information
11.6.2 Singota Solutions Formulation Development CDMO Product Offered
11.6.3 Singota Solutions Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Singota Solutions Main Business Overview
11.6.5 Singota Solutions Latest Developments
11.7 Adragos Pharma
11.7.1 Adragos Pharma Company Information
11.7.2 Adragos Pharma Formulation Development CDMO Product Offered
11.7.3 Adragos Pharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Adragos Pharma Main Business Overview
11.7.5 Adragos Pharma Latest Developments
11.8 Meribel Pharma
11.8.1 Meribel Pharma Company Information
11.8.2 Meribel Pharma Formulation Development CDMO Product Offered
11.8.3 Meribel Pharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Meribel Pharma Main Business Overview
11.8.5 Meribel Pharma Latest Developments
11.9 Eurofins CDMO
11.9.1 Eurofins CDMO Company Information
11.9.2 Eurofins CDMO Formulation Development CDMO Product Offered
11.9.3 Eurofins CDMO Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Eurofins CDMO Main Business Overview
11.9.5 Eurofins CDMO Latest Developments
11.10 Skyepharma
11.10.1 Skyepharma Company Information
11.10.2 Skyepharma Formulation Development CDMO Product Offered
11.10.3 Skyepharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Skyepharma Main Business Overview
11.10.5 Skyepharma Latest Developments
11.11 Siegfried Group
11.11.1 Siegfried Group Company Information
11.11.2 Siegfried Group Formulation Development CDMO Product Offered
11.11.3 Siegfried Group Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Siegfried Group Main Business Overview
11.11.5 Siegfried Group Latest Developments
11.12 Recipharm
11.12.1 Recipharm Company Information
11.12.2 Recipharm Formulation Development CDMO Product Offered
11.12.3 Recipharm Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Recipharm Main Business Overview
11.12.5 Recipharm Latest Developments
11.13 CordenPharma
11.13.1 CordenPharma Company Information
11.13.2 CordenPharma Formulation Development CDMO Product Offered
11.13.3 CordenPharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 CordenPharma Main Business Overview
11.13.5 CordenPharma Latest Developments
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Information
11.14.2 Thermo Fisher Scientific Formulation Development CDMO Product Offered
11.14.3 Thermo Fisher Scientific Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Thermo Fisher Scientific Main Business Overview
11.14.5 Thermo Fisher Scientific Latest Developments
11.15 Samsung Biologics
11.15.1 Samsung Biologics Company Information
11.15.2 Samsung Biologics Formulation Development CDMO Product Offered
11.15.3 Samsung Biologics Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Samsung Biologics Main Business Overview
11.15.5 Samsung Biologics Latest Developments
11.16 AGC Biologics
11.16.1 AGC Biologics Company Information
11.16.2 AGC Biologics Formulation Development CDMO Product Offered
11.16.3 AGC Biologics Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 AGC Biologics Main Business Overview
11.16.5 AGC Biologics Latest Developments
11.17 WuXi AppTec
11.17.1 WuXi AppTec Company Information
11.17.2 WuXi AppTec Formulation Development CDMO Product Offered
11.17.3 WuXi AppTec Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 WuXi AppTec Main Business Overview
11.17.5 WuXi AppTec Latest Developments
11.18 Pharmaron
11.18.1 Pharmaron Company Information
11.18.2 Pharmaron Formulation Development CDMO Product Offered
11.18.3 Pharmaron Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Pharmaron Main Business Overview
11.18.5 Pharmaron Latest Developments
11.19 Asymchem
11.19.1 Asymchem Company Information
11.19.2 Asymchem Formulation Development CDMO Product Offered
11.19.3 Asymchem Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Asymchem Main Business Overview
11.19.5 Asymchem Latest Developments
11.20 Huahai Pharma
11.20.1 Huahai Pharma Company Information
11.20.2 Huahai Pharma Formulation Development CDMO Product Offered
11.20.3 Huahai Pharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Huahai Pharma Main Business Overview
11.20.5 Huahai Pharma Latest Developments
11.21 Nipro Pharma
11.21.1 Nipro Pharma Company Information
11.21.2 Nipro Pharma Formulation Development CDMO Product Offered
11.21.3 Nipro Pharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Nipro Pharma Main Business Overview
11.21.5 Nipro Pharma Latest Developments
11.22 CMIC Group
11.22.1 CMIC Group Company Information
11.22.2 CMIC Group Formulation Development CDMO Product Offered
11.22.3 CMIC Group Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 CMIC Group Main Business Overview
11.22.5 CMIC Group Latest Developments
11.23 Hovione
11.23.1 Hovione Company Information
11.23.2 Hovione Formulation Development CDMO Product Offered
11.23.3 Hovione Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Hovione Main Business Overview
11.23.5 Hovione Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Formulation Development CDMO Market Size (2021-2032)
2.1.2 Formulation Development CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Formulation Development CDMO by Country/Region (2021, 2025 & 2032)
2.2 Formulation Development CDMO Segment by Type
2.2.1 Oral Solid Dosage Forms
2.2.2 Injectable Dosage Forms
2.2.3 Transdermal Dosage Forms
2.2.4 Others
2.2.5 Formulation Development CDMO Market Size by Type
2.2.5.1 Formulation Development CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Formulation Development CDMO Market Size Market Share by Type (2021-2026)
2.3 Formulation Development CDMO Segment by Service Period
2.3.1 3 Months
2.3.2 6 Months
2.3.3 12 Months
2.3.4 24 Months
2.3.5 Others
2.3.6 Formulation Development CDMO Market Size by Service Period
2.3.6.1 Formulation Development CDMO Market Size CAGR by Service Period (2021 VS 2025 VS 2032)
2.3.6.2 Global Formulation Development CDMO Market Size Market Share by Service Period (2021-2026)
2.4 Formulation Development CDMO Segment by Application
2.4.1 Small molecule chemical drugs
2.4.2 Biologics
2.4.3 Cell and gene therapy products
2.4.4 Others
2.4.5 Formulation Development CDMO Market Size by Application
2.4.5.1 Formulation Development CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.5.2 Global Formulation Development CDMO Market Size Market Share by Application (2021-2026)
3 FORMULATION DEVELOPMENT CDMO MARKET SIZE BY PLAYER
3.1 Formulation Development CDMO Market Size Market Share by Player
3.1.1 Global Formulation Development CDMO Revenue by Player (2021-2026)
3.1.2 Global Formulation Development CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Formulation Development CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 FORMULATION DEVELOPMENT CDMO BY REGION
4.1 Formulation Development CDMO Market Size by Region (2021-2026)
4.2 Global Formulation Development CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Formulation Development CDMO Market Size Growth (2021-2026)
4.4 APAC Formulation Development CDMO Market Size Growth (2021-2026)
4.5 Europe Formulation Development CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Formulation Development CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Formulation Development CDMO Market Size by Country (2021-2026)
5.2 Americas Formulation Development CDMO Market Size by Type (2021-2026)
5.3 Americas Formulation Development CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Formulation Development CDMO Market Size by Region (2021-2026)
6.2 APAC Formulation Development CDMO Market Size by Type (2021-2026)
6.3 APAC Formulation Development CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Formulation Development CDMO Market Size by Country (2021-2026)
7.2 Europe Formulation Development CDMO Market Size by Type (2021-2026)
7.3 Europe Formulation Development CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Formulation Development CDMO by Region (2021-2026)
8.2 Middle East & Africa Formulation Development CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Formulation Development CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL FORMULATION DEVELOPMENT CDMO MARKET FORECAST
10.1 Global Formulation Development CDMO Forecast by Region (2027-2032)
10.1.1 Global Formulation Development CDMO Forecast by Region (2027-2032)
10.1.2 Americas Formulation Development CDMO Forecast
10.1.3 APAC Formulation Development CDMO Forecast
10.1.4 Europe Formulation Development CDMO Forecast
10.1.5 Middle East & Africa Formulation Development CDMO Forecast
10.2 Americas Formulation Development CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Formulation Development CDMO Forecast
10.2.2 Canada Market Formulation Development CDMO Forecast
10.2.3 Mexico Market Formulation Development CDMO Forecast
10.2.4 Brazil Market Formulation Development CDMO Forecast
10.3 APAC Formulation Development CDMO Forecast by Region (2027-2032)
10.3.1 China Formulation Development CDMO Market Forecast
10.3.2 Japan Market Formulation Development CDMO Forecast
10.3.3 Korea Market Formulation Development CDMO Forecast
10.3.4 Southeast Asia Market Formulation Development CDMO Forecast
10.3.5 India Market Formulation Development CDMO Forecast
10.3.6 Australia Market Formulation Development CDMO Forecast
10.4 Europe Formulation Development CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Formulation Development CDMO Forecast
10.4.2 France Market Formulation Development CDMO Forecast
10.4.3 UK Market Formulation Development CDMO Forecast
10.4.4 Italy Market Formulation Development CDMO Forecast
10.4.5 Russia Market Formulation Development CDMO Forecast
10.5 Middle East & Africa Formulation Development CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Formulation Development CDMO Forecast
10.5.2 South Africa Market Formulation Development CDMO Forecast
10.5.3 Israel Market Formulation Development CDMO Forecast
10.5.4 Turkey Market Formulation Development CDMO Forecast
10.6 Global Formulation Development CDMO Forecast by Type (2027-2032)
10.7 Global Formulation Development CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Formulation Development CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Formulation Development CDMO Product Offered
11.1.3 Lonza Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Ascendia Pharmaceutical Solutions
11.2.1 Ascendia Pharmaceutical Solutions Company Information
11.2.2 Ascendia Pharmaceutical Solutions Formulation Development CDMO Product Offered
11.2.3 Ascendia Pharmaceutical Solutions Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Ascendia Pharmaceutical Solutions Main Business Overview
11.2.5 Ascendia Pharmaceutical Solutions Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Formulation Development CDMO Product Offered
11.3.3 Catalent Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Cambrex
11.4.1 Cambrex Company Information
11.4.2 Cambrex Formulation Development CDMO Product Offered
11.4.3 Cambrex Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cambrex Main Business Overview
11.4.5 Cambrex Latest Developments
11.5 Ser?n Bioscience
11.5.1 Ser?n Bioscience Company Information
11.5.2 Ser?n Bioscience Formulation Development CDMO Product Offered
11.5.3 Ser?n Bioscience Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Ser?n Bioscience Main Business Overview
11.5.5 Ser?n Bioscience Latest Developments
11.6 Singota Solutions
11.6.1 Singota Solutions Company Information
11.6.2 Singota Solutions Formulation Development CDMO Product Offered
11.6.3 Singota Solutions Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Singota Solutions Main Business Overview
11.6.5 Singota Solutions Latest Developments
11.7 Adragos Pharma
11.7.1 Adragos Pharma Company Information
11.7.2 Adragos Pharma Formulation Development CDMO Product Offered
11.7.3 Adragos Pharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Adragos Pharma Main Business Overview
11.7.5 Adragos Pharma Latest Developments
11.8 Meribel Pharma
11.8.1 Meribel Pharma Company Information
11.8.2 Meribel Pharma Formulation Development CDMO Product Offered
11.8.3 Meribel Pharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Meribel Pharma Main Business Overview
11.8.5 Meribel Pharma Latest Developments
11.9 Eurofins CDMO
11.9.1 Eurofins CDMO Company Information
11.9.2 Eurofins CDMO Formulation Development CDMO Product Offered
11.9.3 Eurofins CDMO Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Eurofins CDMO Main Business Overview
11.9.5 Eurofins CDMO Latest Developments
11.10 Skyepharma
11.10.1 Skyepharma Company Information
11.10.2 Skyepharma Formulation Development CDMO Product Offered
11.10.3 Skyepharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Skyepharma Main Business Overview
11.10.5 Skyepharma Latest Developments
11.11 Siegfried Group
11.11.1 Siegfried Group Company Information
11.11.2 Siegfried Group Formulation Development CDMO Product Offered
11.11.3 Siegfried Group Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Siegfried Group Main Business Overview
11.11.5 Siegfried Group Latest Developments
11.12 Recipharm
11.12.1 Recipharm Company Information
11.12.2 Recipharm Formulation Development CDMO Product Offered
11.12.3 Recipharm Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Recipharm Main Business Overview
11.12.5 Recipharm Latest Developments
11.13 CordenPharma
11.13.1 CordenPharma Company Information
11.13.2 CordenPharma Formulation Development CDMO Product Offered
11.13.3 CordenPharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 CordenPharma Main Business Overview
11.13.5 CordenPharma Latest Developments
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Information
11.14.2 Thermo Fisher Scientific Formulation Development CDMO Product Offered
11.14.3 Thermo Fisher Scientific Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Thermo Fisher Scientific Main Business Overview
11.14.5 Thermo Fisher Scientific Latest Developments
11.15 Samsung Biologics
11.15.1 Samsung Biologics Company Information
11.15.2 Samsung Biologics Formulation Development CDMO Product Offered
11.15.3 Samsung Biologics Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Samsung Biologics Main Business Overview
11.15.5 Samsung Biologics Latest Developments
11.16 AGC Biologics
11.16.1 AGC Biologics Company Information
11.16.2 AGC Biologics Formulation Development CDMO Product Offered
11.16.3 AGC Biologics Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 AGC Biologics Main Business Overview
11.16.5 AGC Biologics Latest Developments
11.17 WuXi AppTec
11.17.1 WuXi AppTec Company Information
11.17.2 WuXi AppTec Formulation Development CDMO Product Offered
11.17.3 WuXi AppTec Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 WuXi AppTec Main Business Overview
11.17.5 WuXi AppTec Latest Developments
11.18 Pharmaron
11.18.1 Pharmaron Company Information
11.18.2 Pharmaron Formulation Development CDMO Product Offered
11.18.3 Pharmaron Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Pharmaron Main Business Overview
11.18.5 Pharmaron Latest Developments
11.19 Asymchem
11.19.1 Asymchem Company Information
11.19.2 Asymchem Formulation Development CDMO Product Offered
11.19.3 Asymchem Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Asymchem Main Business Overview
11.19.5 Asymchem Latest Developments
11.20 Huahai Pharma
11.20.1 Huahai Pharma Company Information
11.20.2 Huahai Pharma Formulation Development CDMO Product Offered
11.20.3 Huahai Pharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Huahai Pharma Main Business Overview
11.20.5 Huahai Pharma Latest Developments
11.21 Nipro Pharma
11.21.1 Nipro Pharma Company Information
11.21.2 Nipro Pharma Formulation Development CDMO Product Offered
11.21.3 Nipro Pharma Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Nipro Pharma Main Business Overview
11.21.5 Nipro Pharma Latest Developments
11.22 CMIC Group
11.22.1 CMIC Group Company Information
11.22.2 CMIC Group Formulation Development CDMO Product Offered
11.22.3 CMIC Group Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 CMIC Group Main Business Overview
11.22.5 CMIC Group Latest Developments
11.23 Hovione
11.23.1 Hovione Company Information
11.23.2 Hovione Formulation Development CDMO Product Offered
11.23.3 Hovione Formulation Development CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Hovione Main Business Overview
11.23.5 Hovione Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Formulation Development CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Formulation Development CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Solid Dosage Forms
Table 4. Major Players of Injectable Dosage Forms
Table 5. Major Players of Transdermal Dosage Forms
Table 6. Major Players of Others
Table 7. Formulation Development CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Table 10. Major Players of 3 Months
Table 11. Major Players of 6 Months
Table 12. Major Players of 12 Months
Table 13. Major Players of 24 Months
Table 14. Major Players of Others
Table 15. Formulation Development CDMO Market Size CAGR by Service Period (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Formulation Development CDMO Market Size by Service Period (2021-2026) & ($ millions)
Table 17. Global Formulation Development CDMO Market Size Market Share by Service Period (2021-2026)
Table 18. Formulation Development CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Table 21. Global Formulation Development CDMO Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Formulation Development CDMO Revenue Market Share by Player (2021-2026)
Table 23. Formulation Development CDMO Key Players Head office and Products Offered
Table 24. Formulation Development CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Formulation Development CDMO Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Formulation Development CDMO Market Size Market Share by Region (2021-2026)
Table 29. Global Formulation Development CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Formulation Development CDMO Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Formulation Development CDMO Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Formulation Development CDMO Market Size Market Share by Country (2021-2026)
Table 33. Americas Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Table 35. Americas Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Table 37. APAC Formulation Development CDMO Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Formulation Development CDMO Market Size Market Share by Region (2021-2026)
Table 39. APAC Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Formulation Development CDMO Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Formulation Development CDMO Market Size Market Share by Country (2021-2026)
Table 43. Europe Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Formulation Development CDMO Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Formulation Development CDMO
Table 49. Key Market Challenges & Risks of Formulation Development CDMO
Table 50. Key Industry Trends of Formulation Development CDMO
Table 51. Global Formulation Development CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Formulation Development CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Formulation Development CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Formulation Development CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Lonza Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 56. Lonza Formulation Development CDMO Product Offered
Table 57. Lonza Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Lonza Main Business
Table 59. Lonza Latest Developments
Table 60. Ascendia Pharmaceutical Solutions Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 61. Ascendia Pharmaceutical Solutions Formulation Development CDMO Product Offered
Table 62. Ascendia Pharmaceutical Solutions Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Ascendia Pharmaceutical Solutions Main Business
Table 64. Ascendia Pharmaceutical Solutions Latest Developments
Table 65. Catalent Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 66. Catalent Formulation Development CDMO Product Offered
Table 67. Catalent Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Catalent Main Business
Table 69. Catalent Latest Developments
Table 70. Cambrex Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 71. Cambrex Formulation Development CDMO Product Offered
Table 72. Cambrex Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Cambrex Main Business
Table 74. Cambrex Latest Developments
Table 75. Ser?n Bioscience Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 76. Ser?n Bioscience Formulation Development CDMO Product Offered
Table 77. Ser?n Bioscience Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Ser?n Bioscience Main Business
Table 79. Ser?n Bioscience Latest Developments
Table 80. Singota Solutions Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 81. Singota Solutions Formulation Development CDMO Product Offered
Table 82. Singota Solutions Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Singota Solutions Main Business
Table 84. Singota Solutions Latest Developments
Table 85. Adragos Pharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 86. Adragos Pharma Formulation Development CDMO Product Offered
Table 87. Adragos Pharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Adragos Pharma Main Business
Table 89. Adragos Pharma Latest Developments
Table 90. Meribel Pharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 91. Meribel Pharma Formulation Development CDMO Product Offered
Table 92. Meribel Pharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Meribel Pharma Main Business
Table 94. Meribel Pharma Latest Developments
Table 95. Eurofins CDMO Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 96. Eurofins CDMO Formulation Development CDMO Product Offered
Table 97. Eurofins CDMO Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Eurofins CDMO Main Business
Table 99. Eurofins CDMO Latest Developments
Table 100. Skyepharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 101. Skyepharma Formulation Development CDMO Product Offered
Table 102. Skyepharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Skyepharma Main Business
Table 104. Skyepharma Latest Developments
Table 105. Siegfried Group Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 106. Siegfried Group Formulation Development CDMO Product Offered
Table 107. Siegfried Group Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Siegfried Group Main Business
Table 109. Siegfried Group Latest Developments
Table 110. Recipharm Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 111. Recipharm Formulation Development CDMO Product Offered
Table 112. Recipharm Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Recipharm Main Business
Table 114. Recipharm Latest Developments
Table 115. CordenPharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 116. CordenPharma Formulation Development CDMO Product Offered
Table 117. CordenPharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. CordenPharma Main Business
Table 119. CordenPharma Latest Developments
Table 120. Thermo Fisher Scientific Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 121. Thermo Fisher Scientific Formulation Development CDMO Product Offered
Table 122. Thermo Fisher Scientific Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Thermo Fisher Scientific Main Business
Table 124. Thermo Fisher Scientific Latest Developments
Table 125. Samsung Biologics Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 126. Samsung Biologics Formulation Development CDMO Product Offered
Table 127. Samsung Biologics Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Samsung Biologics Main Business
Table 129. Samsung Biologics Latest Developments
Table 130. AGC Biologics Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 131. AGC Biologics Formulation Development CDMO Product Offered
Table 132. AGC Biologics Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. AGC Biologics Main Business
Table 134. AGC Biologics Latest Developments
Table 135. WuXi AppTec Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 136. WuXi AppTec Formulation Development CDMO Product Offered
Table 137. WuXi AppTec Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. WuXi AppTec Main Business
Table 139. WuXi AppTec Latest Developments
Table 140. Pharmaron Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 141. Pharmaron Formulation Development CDMO Product Offered
Table 142. Pharmaron Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Pharmaron Main Business
Table 144. Pharmaron Latest Developments
Table 145. Asymchem Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 146. Asymchem Formulation Development CDMO Product Offered
Table 147. Asymchem Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Asymchem Main Business
Table 149. Asymchem Latest Developments
Table 150. Huahai Pharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 151. Huahai Pharma Formulation Development CDMO Product Offered
Table 152. Huahai Pharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Huahai Pharma Main Business
Table 154. Huahai Pharma Latest Developments
Table 155. Nipro Pharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 156. Nipro Pharma Formulation Development CDMO Product Offered
Table 157. Nipro Pharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Nipro Pharma Main Business
Table 159. Nipro Pharma Latest Developments
Table 160. CMIC Group Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 161. CMIC Group Formulation Development CDMO Product Offered
Table 162. CMIC Group Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. CMIC Group Main Business
Table 164. CMIC Group Latest Developments
Table 165. Hovione Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 166. Hovione Formulation Development CDMO Product Offered
Table 167. Hovione Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. Hovione Main Business
Table 169. Hovione Latest Developments
Table 1. Formulation Development CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Formulation Development CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Solid Dosage Forms
Table 4. Major Players of Injectable Dosage Forms
Table 5. Major Players of Transdermal Dosage Forms
Table 6. Major Players of Others
Table 7. Formulation Development CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Table 10. Major Players of 3 Months
Table 11. Major Players of 6 Months
Table 12. Major Players of 12 Months
Table 13. Major Players of 24 Months
Table 14. Major Players of Others
Table 15. Formulation Development CDMO Market Size CAGR by Service Period (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Formulation Development CDMO Market Size by Service Period (2021-2026) & ($ millions)
Table 17. Global Formulation Development CDMO Market Size Market Share by Service Period (2021-2026)
Table 18. Formulation Development CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Table 21. Global Formulation Development CDMO Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Formulation Development CDMO Revenue Market Share by Player (2021-2026)
Table 23. Formulation Development CDMO Key Players Head office and Products Offered
Table 24. Formulation Development CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Formulation Development CDMO Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Formulation Development CDMO Market Size Market Share by Region (2021-2026)
Table 29. Global Formulation Development CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Formulation Development CDMO Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Formulation Development CDMO Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Formulation Development CDMO Market Size Market Share by Country (2021-2026)
Table 33. Americas Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Table 35. Americas Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Table 37. APAC Formulation Development CDMO Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Formulation Development CDMO Market Size Market Share by Region (2021-2026)
Table 39. APAC Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Formulation Development CDMO Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Formulation Development CDMO Market Size Market Share by Country (2021-2026)
Table 43. Europe Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Formulation Development CDMO Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Formulation Development CDMO Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Formulation Development CDMO Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Formulation Development CDMO
Table 49. Key Market Challenges & Risks of Formulation Development CDMO
Table 50. Key Industry Trends of Formulation Development CDMO
Table 51. Global Formulation Development CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Formulation Development CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Formulation Development CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Formulation Development CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Lonza Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 56. Lonza Formulation Development CDMO Product Offered
Table 57. Lonza Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Lonza Main Business
Table 59. Lonza Latest Developments
Table 60. Ascendia Pharmaceutical Solutions Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 61. Ascendia Pharmaceutical Solutions Formulation Development CDMO Product Offered
Table 62. Ascendia Pharmaceutical Solutions Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Ascendia Pharmaceutical Solutions Main Business
Table 64. Ascendia Pharmaceutical Solutions Latest Developments
Table 65. Catalent Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 66. Catalent Formulation Development CDMO Product Offered
Table 67. Catalent Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Catalent Main Business
Table 69. Catalent Latest Developments
Table 70. Cambrex Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 71. Cambrex Formulation Development CDMO Product Offered
Table 72. Cambrex Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Cambrex Main Business
Table 74. Cambrex Latest Developments
Table 75. Ser?n Bioscience Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 76. Ser?n Bioscience Formulation Development CDMO Product Offered
Table 77. Ser?n Bioscience Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Ser?n Bioscience Main Business
Table 79. Ser?n Bioscience Latest Developments
Table 80. Singota Solutions Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 81. Singota Solutions Formulation Development CDMO Product Offered
Table 82. Singota Solutions Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Singota Solutions Main Business
Table 84. Singota Solutions Latest Developments
Table 85. Adragos Pharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 86. Adragos Pharma Formulation Development CDMO Product Offered
Table 87. Adragos Pharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Adragos Pharma Main Business
Table 89. Adragos Pharma Latest Developments
Table 90. Meribel Pharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 91. Meribel Pharma Formulation Development CDMO Product Offered
Table 92. Meribel Pharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Meribel Pharma Main Business
Table 94. Meribel Pharma Latest Developments
Table 95. Eurofins CDMO Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 96. Eurofins CDMO Formulation Development CDMO Product Offered
Table 97. Eurofins CDMO Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Eurofins CDMO Main Business
Table 99. Eurofins CDMO Latest Developments
Table 100. Skyepharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 101. Skyepharma Formulation Development CDMO Product Offered
Table 102. Skyepharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Skyepharma Main Business
Table 104. Skyepharma Latest Developments
Table 105. Siegfried Group Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 106. Siegfried Group Formulation Development CDMO Product Offered
Table 107. Siegfried Group Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Siegfried Group Main Business
Table 109. Siegfried Group Latest Developments
Table 110. Recipharm Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 111. Recipharm Formulation Development CDMO Product Offered
Table 112. Recipharm Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Recipharm Main Business
Table 114. Recipharm Latest Developments
Table 115. CordenPharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 116. CordenPharma Formulation Development CDMO Product Offered
Table 117. CordenPharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. CordenPharma Main Business
Table 119. CordenPharma Latest Developments
Table 120. Thermo Fisher Scientific Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 121. Thermo Fisher Scientific Formulation Development CDMO Product Offered
Table 122. Thermo Fisher Scientific Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Thermo Fisher Scientific Main Business
Table 124. Thermo Fisher Scientific Latest Developments
Table 125. Samsung Biologics Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 126. Samsung Biologics Formulation Development CDMO Product Offered
Table 127. Samsung Biologics Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Samsung Biologics Main Business
Table 129. Samsung Biologics Latest Developments
Table 130. AGC Biologics Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 131. AGC Biologics Formulation Development CDMO Product Offered
Table 132. AGC Biologics Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. AGC Biologics Main Business
Table 134. AGC Biologics Latest Developments
Table 135. WuXi AppTec Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 136. WuXi AppTec Formulation Development CDMO Product Offered
Table 137. WuXi AppTec Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. WuXi AppTec Main Business
Table 139. WuXi AppTec Latest Developments
Table 140. Pharmaron Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 141. Pharmaron Formulation Development CDMO Product Offered
Table 142. Pharmaron Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Pharmaron Main Business
Table 144. Pharmaron Latest Developments
Table 145. Asymchem Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 146. Asymchem Formulation Development CDMO Product Offered
Table 147. Asymchem Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Asymchem Main Business
Table 149. Asymchem Latest Developments
Table 150. Huahai Pharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 151. Huahai Pharma Formulation Development CDMO Product Offered
Table 152. Huahai Pharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Huahai Pharma Main Business
Table 154. Huahai Pharma Latest Developments
Table 155. Nipro Pharma Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 156. Nipro Pharma Formulation Development CDMO Product Offered
Table 157. Nipro Pharma Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Nipro Pharma Main Business
Table 159. Nipro Pharma Latest Developments
Table 160. CMIC Group Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 161. CMIC Group Formulation Development CDMO Product Offered
Table 162. CMIC Group Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. CMIC Group Main Business
Table 164. CMIC Group Latest Developments
Table 165. Hovione Details, Company Type, Formulation Development CDMO Area Served and Its Competitors
Table 166. Hovione Formulation Development CDMO Product Offered
Table 167. Hovione Formulation Development CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. Hovione Main Business
Table 169. Hovione Latest Developments
LIST OF FIGURES
Figure 1. Formulation Development CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Formulation Development CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Formulation Development CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Formulation Development CDMO Sales Market Share by Country/Region (2025)
Figure 8. Formulation Development CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Formulation Development CDMO Market Size Market Share by Type in 2025
Figure 10. Global Formulation Development CDMO Market Size Market Share by Service Period in 2025
Figure 11. Formulation Development CDMO in Small molecule chemical drugs
Figure 12. Global Formulation Development CDMO Market: Small molecule chemical drugs (2021-2026) & ($ millions)
Figure 13. Formulation Development CDMO in Biologics
Figure 14. Global Formulation Development CDMO Market: Biologics (2021-2026) & ($ millions)
Figure 15. Formulation Development CDMO in Cell and gene therapy products
Figure 16. Global Formulation Development CDMO Market: Cell and gene therapy products (2021-2026) & ($ millions)
Figure 17. Formulation Development CDMO in Others
Figure 18. Global Formulation Development CDMO Market: Others (2021-2026) & ($ millions)
Figure 19. Global Formulation Development CDMO Market Size Market Share by Application in 2025
Figure 20. Global Formulation Development CDMO Revenue Market Share by Player in 2025
Figure 21. Global Formulation Development CDMO Market Size Market Share by Region (2021-2026)
Figure 22. Americas Formulation Development CDMO Market Size 2021-2026 ($ millions)
Figure 23. APAC Formulation Development CDMO Market Size 2021-2026 ($ millions)
Figure 24. Europe Formulation Development CDMO Market Size 2021-2026 ($ millions)
Figure 25. Middle East & Africa Formulation Development CDMO Market Size 2021-2026 ($ millions)
Figure 26. Americas Formulation Development CDMO Value Market Share by Country in 2025
Figure 27. United States Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Canada Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Mexico Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. Brazil Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 31. APAC Formulation Development CDMO Market Size Market Share by Region in 2025
Figure 32. APAC Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Figure 33. APAC Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Figure 34. China Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. Japan Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. South Korea Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Southeast Asia Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. India Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Australia Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 40. Europe Formulation Development CDMO Market Size Market Share by Country in 2025
Figure 41. Europe Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Figure 42. Europe Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Figure 43. Germany Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. France Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. UK Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Italy Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Russia Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 48. Middle East & Africa Formulation Development CDMO Market Size Market Share by Region (2021-2026)
Figure 49. Middle East & Africa Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Figure 50. Middle East & Africa Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Figure 51. Egypt Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. South Africa Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Israel Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. Turkey Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. GCC Countries Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 56. Americas Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 57. APAC Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 58. Europe Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 59. Middle East & Africa Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 60. United States Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 61. Canada Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 62. Mexico Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 63. Brazil Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 64. China Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 65. Japan Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 66. Korea Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 67. Southeast Asia Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 68. India Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 69. Australia Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 70. Germany Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 71. France Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 72. UK Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 73. Italy Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 74. Russia Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 75. Egypt Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 76. South Africa Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 77. Israel Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 78. Turkey Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 79. Global Formulation Development CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 80. Global Formulation Development CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 81. GCC Countries Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 1. Formulation Development CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Formulation Development CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Formulation Development CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Formulation Development CDMO Sales Market Share by Country/Region (2025)
Figure 8. Formulation Development CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Formulation Development CDMO Market Size Market Share by Type in 2025
Figure 10. Global Formulation Development CDMO Market Size Market Share by Service Period in 2025
Figure 11. Formulation Development CDMO in Small molecule chemical drugs
Figure 12. Global Formulation Development CDMO Market: Small molecule chemical drugs (2021-2026) & ($ millions)
Figure 13. Formulation Development CDMO in Biologics
Figure 14. Global Formulation Development CDMO Market: Biologics (2021-2026) & ($ millions)
Figure 15. Formulation Development CDMO in Cell and gene therapy products
Figure 16. Global Formulation Development CDMO Market: Cell and gene therapy products (2021-2026) & ($ millions)
Figure 17. Formulation Development CDMO in Others
Figure 18. Global Formulation Development CDMO Market: Others (2021-2026) & ($ millions)
Figure 19. Global Formulation Development CDMO Market Size Market Share by Application in 2025
Figure 20. Global Formulation Development CDMO Revenue Market Share by Player in 2025
Figure 21. Global Formulation Development CDMO Market Size Market Share by Region (2021-2026)
Figure 22. Americas Formulation Development CDMO Market Size 2021-2026 ($ millions)
Figure 23. APAC Formulation Development CDMO Market Size 2021-2026 ($ millions)
Figure 24. Europe Formulation Development CDMO Market Size 2021-2026 ($ millions)
Figure 25. Middle East & Africa Formulation Development CDMO Market Size 2021-2026 ($ millions)
Figure 26. Americas Formulation Development CDMO Value Market Share by Country in 2025
Figure 27. United States Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Canada Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Mexico Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. Brazil Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 31. APAC Formulation Development CDMO Market Size Market Share by Region in 2025
Figure 32. APAC Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Figure 33. APAC Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Figure 34. China Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. Japan Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. South Korea Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Southeast Asia Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. India Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Australia Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 40. Europe Formulation Development CDMO Market Size Market Share by Country in 2025
Figure 41. Europe Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Figure 42. Europe Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Figure 43. Germany Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. France Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. UK Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Italy Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Russia Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 48. Middle East & Africa Formulation Development CDMO Market Size Market Share by Region (2021-2026)
Figure 49. Middle East & Africa Formulation Development CDMO Market Size Market Share by Type (2021-2026)
Figure 50. Middle East & Africa Formulation Development CDMO Market Size Market Share by Application (2021-2026)
Figure 51. Egypt Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. South Africa Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Israel Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. Turkey Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. GCC Countries Formulation Development CDMO Market Size Growth 2021-2026 ($ millions)
Figure 56. Americas Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 57. APAC Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 58. Europe Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 59. Middle East & Africa Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 60. United States Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 61. Canada Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 62. Mexico Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 63. Brazil Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 64. China Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 65. Japan Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 66. Korea Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 67. Southeast Asia Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 68. India Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 69. Australia Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 70. Germany Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 71. France Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 72. UK Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 73. Italy Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 74. Russia Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 75. Egypt Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 76. South Africa Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 77. Israel Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 78. Turkey Formulation Development CDMO Market Size 2027-2032 ($ millions)
Figure 79. Global Formulation Development CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 80. Global Formulation Development CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 81. GCC Countries Formulation Development CDMO Market Size 2027-2032 ($ millions)
